Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Head & Neck 2Tumor-Agnostic 1

Conditions

Neoplasms 43Breast Neoplasms 31Prostatic Neoplasms 27Colorectal Neoplasms 26Lung Neoplasms 17Hematopoietic and Lymphatic System Neoplasm 12Ovarian Neoplasms 11Hematologic Neoplasms 11Uterine Cervical Neoplasms 7Multiple Myeloma 7Lymphoma 7Leukemia 7Head and Neck Neoplasms 6Endometrial Neoplasms 6Depression 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Pancreatic Neoplasms 5Leukemia, Myeloid, Acute 5Urinary Bladder Neoplasms 4Rectal Neoplasms 4Mouth Neoplasms 4Motor Activity 4Melanoma 4Hematopoietic and Lymphoid System Neoplasm 4Gastrointestinal Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Anxiety Disorders 4Advanced Cancer 4Triple Negative Breast Neoplasms 3Stomach Neoplasms 3

Interventions

Cisplatin 21pembrolizumab 16Gemcitabine 16Paclitaxel 15Radiotherapy 14Carboplatin 14Radiotherapy, Intensity-Modulated 13Cyclophosphamide 9Cetuximab 9Magnetic Resonance Spectroscopy 8Radiation 7padeliporfin 6Specimen Handling 6Oxaliplatin 6Fluorouracil 6Drug Therapy 6Docetaxel 6Capecitabine 6Bevacizumab 6anlotinib 5Nivolumab 5Irinotecan 5Erlotinib Hydrochloride 5Celecoxib 5poly ICLC 4fludarabine 4Standard of Care 4Sorafenib 4Leucovorin 4Ipilimumab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Carcinoma × Interviews as Topic × Clear all
NCT06997068 2026-05-11

Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population

Mayo Clinic

Phase 2 Recruiting
25 enrolled
Head & Neck

Carcinoma, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

NCT06662058 2026-04-23

Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation

Emory University

Phase NA Recruiting
118 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

NCT01148082 2017-06-26

School Response to Families Who Have Children With Cancer

Stanford University

Withdrawn
Tumor-Agnostic

Adenocarcinoma, Carcinoma, Carcinoma, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡